Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Solveig Hofvind

Showing results (141-150 of 228) with videos related to

Pageof 23
Sort By:
The Lancet Regional Health. Europe|March 23, 2026
Effect of reminder phone calls in the language of origin on colorectal cancer screening participation among immigrants in Norway: a randomised controlled trialNadia Iqbal, Sameer Bhargava, Solveig Hofvind, et al.
Acta Radiologica Open|October 8, 2015
Mammographic density and histopathologic characteristics of screen-detected tumors in the Norwegian Breast Cancer Screening ProgramNataliia Moshina, Giske Ursin, Solveig Roth Hoff, et al.
British Journal of Cancer|August 20, 2025
Correction: Menopausal hormone therapy and breast cancer risk: a population-based cohort study of 1.3 million women in NorwayNathalie C Støer, Siri Vangen, Deependra Singh, et al.
British Journal of Cancer|May 13, 2024
Menopausal hormone therapy and breast cancer risk: a population-based cohort study of 1.3 million women in NorwayNathalie C Støer, Siri Vangen, Deependra Singh, et al.
Breast Cancer Research and Treatment|February 12, 2018
Performance of breast cancer screening using digital breast tomosynthesis: results from the prospective population-based Oslo Tomosynthesis Screening TrialPer Skaane, Sofie Sebuødegård, Andriy I Bandos, et al.
Breast Cancer Research and Treatment|November 5, 2011
Hormone therapy use and mammographic density in postmenopausal Norwegian womenElisabeth Couto, Samera Azeem Qureshi, Solveig Hofvind, et al.
Journal of Breast Imaging|March 1, 2024
Self-reported Pain Associated With Screening With Digital Breast TomosynthesisNataliia Moshina, Anders Skyrud Danielsen, Åsne Sørlien Hølen, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 26, 2021
Quality of life among women with symptomatic, screen-detected, and interval breast cancer, and for women without breast cancer: a retrospective cross-sectional study from NorwayNataliia Moshina, Ragnhild S Falk, Edoardo Botteri, et al.
European Journal of Epidemiology|August 8, 2018
Menopausal hormone therapy and breast cancer risk: effect modification by body mass through lifeMarie Søfteland Sandvei, Lars J Vatten, Elisabeth Krefting Bjelland, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 27, 2025
Correction: Quality of life among women with symptomatic, screen‑detected, and interval breast cancer, and for women without breast cancer: a retrospective cross‑sectional study from NorwayNataliia Moshina, Ragnhild S Falk, Edoardo Botteri, et al.
Pageof 23

Showing results (141-150 of 228) with videos related to

Sort By:
Pageof 23
The Lancet Regional Health. Europe|March 23, 2026
Effect of reminder phone calls in the language of origin on colorectal cancer screening participation among immigrants in Norway: a randomised controlled trialNadia Iqbal, Sameer Bhargava, Solveig Hofvind, et al.
Acta Radiologica Open|October 8, 2015
Mammographic density and histopathologic characteristics of screen-detected tumors in the Norwegian Breast Cancer Screening ProgramNataliia Moshina, Giske Ursin, Solveig Roth Hoff, et al.
British Journal of Cancer|August 20, 2025
Correction: Menopausal hormone therapy and breast cancer risk: a population-based cohort study of 1.3 million women in NorwayNathalie C Støer, Siri Vangen, Deependra Singh, et al.
British Journal of Cancer|May 13, 2024
Menopausal hormone therapy and breast cancer risk: a population-based cohort study of 1.3 million women in NorwayNathalie C Støer, Siri Vangen, Deependra Singh, et al.
Breast Cancer Research and Treatment|February 12, 2018
Performance of breast cancer screening using digital breast tomosynthesis: results from the prospective population-based Oslo Tomosynthesis Screening TrialPer Skaane, Sofie Sebuødegård, Andriy I Bandos, et al.
Breast Cancer Research and Treatment|November 5, 2011
Hormone therapy use and mammographic density in postmenopausal Norwegian womenElisabeth Couto, Samera Azeem Qureshi, Solveig Hofvind, et al.
Journal of Breast Imaging|March 1, 2024
Self-reported Pain Associated With Screening With Digital Breast TomosynthesisNataliia Moshina, Anders Skyrud Danielsen, Åsne Sørlien Hølen, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 26, 2021
Quality of life among women with symptomatic, screen-detected, and interval breast cancer, and for women without breast cancer: a retrospective cross-sectional study from NorwayNataliia Moshina, Ragnhild S Falk, Edoardo Botteri, et al.
European Journal of Epidemiology|August 8, 2018
Menopausal hormone therapy and breast cancer risk: effect modification by body mass through lifeMarie Søfteland Sandvei, Lars J Vatten, Elisabeth Krefting Bjelland, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 27, 2025
Correction: Quality of life among women with symptomatic, screen‑detected, and interval breast cancer, and for women without breast cancer: a retrospective cross‑sectional study from NorwayNataliia Moshina, Ragnhild S Falk, Edoardo Botteri, et al.
Pageof 23